☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Aptinyx
PharmaShots Weekly Snapshots (August 22 - 26, 2022)
August 26, 2022
Aptinyx Reports the Completion of Patient Enrollment of NYX-458 in P-II Study for Cognitive Impairment
August 26, 2022
PharmaShots Weekly Snapshots (April 04-08, 2022)
April 8, 2022
Aptinyx Reports Results of NYX-2925 in P-IIb Study for the Treatment of Painful Diabetic Peripheral Neuropathy
April 8, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.
